Revelation Biosciences, Inc.
REVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810560
No open-market purchases or sales by Revelation Biosciences, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $313.2K in total; no superinvestor holds it.
Other share classesREVBW
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Revelation Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Revelation Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Rolke James | Chief Executive Officer | 422,814 | Aug 18, 2026 | 5 |
| Chawla Lakhmir S | Director | 44,169 | Aug 18, 2026 | 4 |
| Zygmont Chester Stanley III | Chief Financial Officer | 300,136Indirect | Aug 18, 2026 | 5 |
| Roper Jess | Director | 44,839 | Aug 18, 2026 | 4 |
| Carver Jennifer | Director | 44,769 | Aug 18, 2026 | 4 |
| Tidmarsh George F | Director | 268Indirect | Feb 13, 2025 | 0 |
| LaBelle Curt H | Director | – | Apr 18, 2023 | 0 |
| Feis Lawrence | 10% Owner | 0Indirect | Jan 11, 2022 | 0 |
| Feis Equities LLC | 10% Owner | 0Indirect | Jan 11, 2022 | 0 |
| Glazer Capital, LLC | 10% Owner | 381,106Indirect | Sep 23, 2021 | 0 |
| Glazer Paul J | 10% Owner | 381,106Indirect | Sep 23, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2023 (view filing) | Dec 8 | 4 days | Tidmarsh George FDirector | SSale | −27.8K | $0.52 | −$14.4K | −100.0%0 after | |
| Oct 18, 2023 (view filing) | Oct 16 | 2 days | Tidmarsh George FDirector | SSale | −1.84K | $0.65 | −$1.20K | −6.2%27.8K after | |
| Oct 17, 2023 (view filing) | Oct 16 | 1 day | Tidmarsh George FDirector | SSale | −11.0K | $0.66 | −$7.23K | −20.7%42.1K after | |
| Oct 2, 2023 (view filing) | Sep 28 | 4 days | Tidmarsh George FDirector | SSale | −1.43K | $0.69 | −$986.01 | −3.3%42.1K after | |
| Sep 18, 2023 (view filing) | Sep 14-18 | 4 days | Tidmarsh George FDirector | SSale | −25.5K | $0.741 | −$18.9K | −39.3%39.3K after | 3 lots |
| Apr 19, 2023 (view filing) | Apr 17-18 | 2 days | Tidmarsh George FDirector | PPurchase | +51.5K | $1.16 | +$59.7K | +385.8%64.8K after | 2 lots |
| Feb 28, 2022 (view filing) | Feb 25 | 3 days | Tidmarsh George FDirector, 10% Owner | PPurchase | +20.0K | $1.60 | +$32.0K | +4.5%467.2K after | |
| Feb 10, 2022 (view filing) | Feb 8-9 | 2 days | Tidmarsh George FDirector, 10% Owner | PPurchase | +31.0K | $2.55 | +$79.0K | +7.4%447.2K after | 2 lots |
| Feb 9, 2022 (view filing) | Feb 4-7 | 5 days | Tidmarsh George FDirector, 10% Owner | PPurchase | +50.0K | $2.56 | +$128.1K | +3.4%1.52M after | Amended2 lots |
| Feb 9, 2022 (view filing) | Feb 4 | 5 days | Tidmarsh George FDirector, 10% Owner | PPurchase | +2.00K | $2.45 | +$4.90K | +0.5%416.2K after | Amended |
| Sep 23, 2021 (view filing)4:21 PM ET | Sep 21-23 | 2 days | Glazer Capital, LLC and 1 other10% Owner | SSaleCommon stock, $0.001 par value per share | −654.5K | $10.08 | −$6.60M | −63.2%381.1K after | 3 lots |